Iontophoresis is a clinically-proven technology that transports ingredients into the skin to their necessary therapeutic levels.
ActivaTek Inc. is an innovative company that develops and markets drug delivery and other medical devices. The company developed its first iontophoretic product for the rehabilitation market in 2006; the Trivarion®, a buffered, active transdermal drug (iontophoresis) technology that delivers drugs comfortably through the skin using a constant DC current. Iontophoresis (as a drug delivery vehicle) has been marketed for over 25 years to treat acute local inflammatory conditions and provide local skin anesthesia.
Since that time, ActivaTek has continued to change the shape of iontophoresis with innovation and advanced technologies. In addition to providing the industry with a unique and flexible shape in the Trivarion®, we have developed and successfully launched the ActivaDose® II, the ActivaPatch® (a self-contained, wireless alternative to traditional modalities), and most recently, the Trivarion® Butterfly. ActivaTek’s technology offers the most advanced and flexible products on the market, and allows for precise dosing; thus providing physical therapists and other medical professionals with unparalleled control of delivery.
ActivaTek, Inc. is proud to be a Partner in Research with the Foundation for Therapy for 2010. Key partners aid in the Foundation’s mission of advancing the physical therapy profession through support of scientifically-based and clinically-relevant research.